郭藩盛, 曾强, 窦剑. 肝移植受者戊型肝炎病毒感染[J]. 器官移植, 2024, 15(3): 352-358. DOI: 10.3969/j.issn.1674-7445.2023216
引用本文: 郭藩盛, 曾强, 窦剑. 肝移植受者戊型肝炎病毒感染[J]. 器官移植, 2024, 15(3): 352-358. DOI: 10.3969/j.issn.1674-7445.2023216
Guo Fansheng, Zeng Qiang, Dou Jian. Hepatitis E virus infection in liver transplant recipients[J]. ORGAN TRANSPLANTATION, 2024, 15(3): 352-358. DOI: 10.3969/j.issn.1674-7445.2023216
Citation: Guo Fansheng, Zeng Qiang, Dou Jian. Hepatitis E virus infection in liver transplant recipients[J]. ORGAN TRANSPLANTATION, 2024, 15(3): 352-358. DOI: 10.3969/j.issn.1674-7445.2023216

肝移植受者戊型肝炎病毒感染

Hepatitis E virus infection in liver transplant recipients

  • 摘要: 戊型肝炎病毒感染是急性病毒性肝炎的常见病因。近年来,戊型肝炎发病率呈上升趋势,逐渐成为世界范围内急性病毒性肝炎的重要病因。年龄、性别、免疫抑制强度、经济社会因素均是戊型肝炎病毒感染的危险因素。肝移植受者术后需长期应用免疫抑制药进行抗排斥反应治疗,处于免疫抑制状态,易感染戊型肝炎病毒且有引起肝纤维化及肝硬化的风险。因此,在临床工作中应重点关注肝移植受者,同时应进一步明确相关危险因素,以便辅助诊断和采取更严格的预防措施。本文根据现有文献对戊型肝炎病毒病原学特点以及肝移植受者戊型肝炎病毒感染的流行病学特征、临床表现、诊断及治疗进行综述,以期在临床上更好地对肝移植受者戊型肝炎病毒感染进行监测、治疗及预防,改善肝移植受者的预后。

     

    Abstract: Hepatitis E virus infection is a common cause of acute viral hepatitis. In recent years, the incidence of hepatitis E has shown an increasing trend, which has gradually become an important cause of acute viral hepatitis worldwide. Age, sex, intensity of immunosuppression and socio-economic factors are all risk factors for hepatitis E virus infection. Liver transplant recipients require long-term use of immunosuppressive drugs for anti rejection treatment, prone to hepatitis E virus infection and at the risk of liver fibrosis and cirrhosis due to immunosuppression status. Therefore, special attention should be paid to liver transplant recipients in clinical practice. Meantime, related risk factors should be identified to assist diagnosis and take stricter preventive measures. According to literature review, the etiological characteristics of hepatitis E virus and the epidemiological characteristics, clinical manifestations, diagnosis and treatment of hepatitis E virus infection in liver transplant recipients were reviewed, aiming to properly monitor, treat and prevent hepatitis E virus infection in liver transplant recipients in clinical practice, improving the prognosis of liver transplant recipients.

     

/

返回文章
返回